Big Data In Health Care: Using Analytics To Identify And Manage High-Risk And High-Cost Patients

被引:670
作者
Bates, David W. [1 ]
Saria, Suchi [2 ]
Ohno-Machado, Lucila [3 ]
Shah, Anand [4 ]
Escobar, Gabriel [5 ,6 ]
机构
[1] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA
[2] Johns Hopkins Univ, Ctr Populat Hlth & IT, Baltimore, MD USA
[3] Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA
[4] PCCI, Dallas, TX USA
[5] Kaiser Permanente, Oakland, CA USA
[6] Kaiser Permanente, Div Res, Syst Res Initiat, Oakland, CA USA
关键词
ADVERSE DRUG EVENTS; EARLY-ONSET SEPSIS; HOSPITAL READMISSIONS; MORTALITY; RECORD; ADULTS; MULTIMORBIDITY; PREVALENCE; PREDICTION; BIRTH;
D O I
10.1377/hlthaff.2014.0041
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The US health care system is rapidly adopting electronic health records, which will dramatically increase the quantity of clinical data that are available electronically. Simultaneously, rapid progress has been made in clinical analytics-techniques for analyzing large quantities of data and gleaning new insights from that analysis-which is part of what is known as big data. As a result, there are unprecedented opportunities to use big data to reduce the costs of health care in the United States. We present six use cases-that is, key examples-where some of the clearest opportunities exist to reduce costs through the use of big data: high-cost patients, readmissions, triage, decompensation (when a patient's condition worsens), adverse events, and treatment optimization for diseases affecting multiple organ systems. We discuss the types of insights that are likely to emerge from clinical analytics, the types of data needed to obtain such insights, and the infrastructure-analytics, algorithms, registries, assessment scores, monitoring devices, and so forth-that organizations will need to perform the necessary analyses and to implement changes that will improve care while reducing costs. Our findings have policy implications for regulatory oversight, ways to address privacy concerns, and the support of research on analytics.
引用
收藏
页码:1123 / 1131
页数:9
相关论文
共 71 条
[1]   Concern about security and privacy, and perceived control over collection and use of health information are related to withholding of health information from healthcare providers [J].
Agaku, Israel T. ;
Adisa, Akinyele O. ;
Ayo-Yusuf, Olalekan A. ;
Connolly, Gregory N. .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2014, 21 (02) :374-378
[2]  
[Anonymous], HOME PAGE ON THE INT
[3]  
APGAR V, 1966, PEDIATR CLIN N AM, V13, P645
[4]   Measuring value for money: a scoping review on economic evaluation of health information systems [J].
Bassi, Jesdeep ;
Lau, Francis .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2013, 20 (04) :792-+
[5]   Drugs and adverse drug reactions - How worried should we be? [J].
Bates, DW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1216-1217
[6]   Mortality and costs of acute renal failure associated with amphotericin B therapy [J].
Bates, DW ;
Su, L ;
Yu, DT ;
Chertow, GM ;
Seger, DL ;
Gomes, DRJ ;
Dasbach, EJ ;
Platt, R .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) :686-693
[7]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[8]  
Bates DW., DRAFT FDASIA COMMITT
[9]  
Bayati M., 2011, DATA DRIVEN DECISION
[10]   Continuous Monitoring in an Inpatient Medical-Surgical Unit: A Controlled Clinical Trial [J].
Brown, Harvey ;
Terrence, Jamie ;
Vasquez, Patricia ;
Bates, David W. ;
Zimlichman, Eyal .
AMERICAN JOURNAL OF MEDICINE, 2014, 127 (03) :226-232